Meiotic Origins of Down Syndrome: Nondisjunction and Translocation

Down syndrome (trisomy 21) results from an extra copy of chromosome 21, typically arising from errors in meiosis during gamete formation.

Mechanism 1: Meiotic Nondisjunction (~95% of cases)

  • Meiosis I error: Homologous chromosome 21 pair fails to separate → egg/sperm with two chr21 copies. Fertilization by normal gamete → trisomy 21 in all cells.
  • Meiosis II error: Sister chromatids fail to separate → similar outcome.
  • Maternal origin: ~90% of nondisjunction events occur in oogenesis; risk increases sharply with maternal age (especially >35).
  • Paternal origin: ~5–10%; less age-dependent.
  • Post-zygotic mitotic error: Rare; causes mosaic Down syndrome (some cells 46,XX/XY; others 47,XX,+21/47,XY,+21).

Mechanism 2: Robertsonian Translocation (~3–4%)

  • Long arm of chr21 fuses to another acrocentric chromosome (usually 14, 21, or 22): t(14;21) or t(21;21).
  • Carrier parent has 45 chromosomes but balanced genetic material (phenotypically normal).
  • Gametes can carry derivative chromosome + normal chr21 → trisomy 21 conceptus.
  • t(21;21) carriers: 100% risk of Down syndrome offspring (all gametes carry two chr21 copies).
  • Not associated with maternal age.

Mechanism 3: Mosaicism (~1–2%)

Post-zygotic mitotic nondisjunction → two cell lines. Phenotype varies with proportion of trisomic cells and tissues affected.

Epidemiology

  • Incidence: ~1 in 700 live births (US)
  • Most common autosomal aneuploidy
  • Leading genetic cause of intellectual disability

Clinical Implications

Karyotyping distinguishes mechanisms. Translocation carriers need genetic counseling for recurrence risk (10–15% if mother carrier, ~3% if father carrier for t(14;21)). Prenatal screening (NIPT, combined test) and diagnosis (CVS, amniocentesis) available.

Genetic Disorders - Related Articles